DCTH Delcath Systems, Inc. - Common Stock
NASDAQ · Health Care · Lihat di SEC EDGAR ↗ tutup Okt 5, 2026 10-K/10-Q Agu 6, 2026
$15,49
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$8,12rendah 52m
$17,42tinggi 52m
Kapitalisasi Pasar (MRQ)
$537M
P/E (TTM)
1549.0
EPS (TTM)
$0.01
Pendapatan (TTM)
$95M
lencana Anda
Rentang 52M
$8–$17
Peringkat Analis
BUY
Target Harga
$24
P/E
1549.0
ROE
0.47%
Margin Laba Bersih
0.56%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
DCTH Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$15.49
Kapitalisasi Pasar (MRQ)
$537M
P/E (TTM)
1549.0
EPS (TTM)
$0.01
Pendapatan (TTM)
$95M
ROE (TTM)
0.47%
Rentang 52M
$8–$17
DCTH Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 24 Des. 2019 | 1-for-700 | Terbalik |
Tentang Delcath Systems, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealth Care
industriHealth Care
karyawan156
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$85M2016-12-31 → 2025-12-31
EPS$0.072017-12-31 → 2025-12-31
Arus Kas Bebas$21M2018-12-31 → 2025-12-31
Margin bersih0.56%2022-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | DCTH | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 1549.0rata-rata 5T ≈25.4 | ≈25.4 | · | · | |
| P/S (TTM) | 5.6rata-rata 5T ≈17.7 | ≈17.7 | 3.7 | Terlalu mahal | |
| P/B (MRQ) | 4.4rata-rata 5T ≈3.0 | ≈3.0 | 3.4 | Terlalu mahal | |
| Harga / FCF (TTM) | 30.6rata-rata 5T ≈-2.2 | ≈-2.2 | · | · | |
| Harga / Arus Kas (TTM) | 27.4rata-rata 5T ≈-2.5 | ≈-2.5 | 18.5 | Kurang nilai | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 4.8rata-rata 5T ≈5.0 | ≈5.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | DCTH | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Kotor (TTM) | 87.1%rata-rata 5T ≈78.4% | ≈78.4% | 73.6% | Tingkat teratas | |
| Margin Operasi (TTM) | -1.9%rata-rata 5T ≈-781.7% | ≈-781.7% | -8.2% | Tingkat teratas | |
| EBITDA Margin (Margin EBITDA) | 0.77%rata-rata 5T ≈-781.7% | ≈-781.7% | -5.0% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | 1.4%rata-rata 5T ≈-929.6% | ≈-929.6% | -11.3% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | 0.56%rata-rata 5T ≈-929.8% | ≈-929.8% | -13.1% | Tingkat teratas | |
| ROA (TTM) | 0.42%rata-rata 5T ≈-86.2% | ≈-86.2% | -16.0% | Tingkat teratas | |
| ROE (TTM) | 0.47%rata-rata 5T ≈27.9% | ≈27.9% | -25.7% | Tingkat teratas | |
| ROIC | 0.46%rata-rata 5T ≈22.6% | ≈22.6% | -23.7% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | DCTH | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 9.8rata-rata 5T ≈6.3 | ≈6.3 | 3.5 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 5.0rata-rata 5T ≈3.5 | ≈3.5 | 2.2 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | DCTH | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 129.1%rata-rata 5T ≈445.8% | ≈445.8% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 215.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | DCTH | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.9rata-rata 5T ≈0.4 | ≈0.4 | 0.8 | Sejajar | |
| Inventory Turnover (Perputaran Persediaan) | 1.4rata-rata 5T ≈0.8 | ≈0.8 | 1.7 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 7.5rata-rata 5T ≈8.6 | ≈8.6 | 7.3 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$546.4K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
88.6%
Laporan Berikutnya
Nov 02, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $0.07 | $-0.09 | 176.3% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.03 | $-0.09 | 66.1% |
| 31 Des. 2025 | $-0.05 | $-0.06 | 20.5% | |
| 30 Sep. 2025 | $0.02 | $0.02 | -2.0% | |
| 30 Juni 2025 | $0.07 | $0.03 | 174.5% | |
| 31 Maret 2025 | $0.03 | $0.02 | 96.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.21 | $2.08 | $0.69 | $-0.74 | $1.51 | $3.68 | $-94.75 | $-1.46 | · | · | $0.40 | $1.87 | |
| Revenue / Share | $2.14 | $1.30 | $0.13 | $0.31 | · | · | · | · | · | · | $0.11 | $0.11 | |
| Cash Flow / Share | $0.56 | $-0.66 | $-1.93 | $-2.81 | · | $-7.89 | · | $-0.55 | · | · | $-1.02 | $-1.65 | |
| Cash / Share | $1.25 | $0.98 | $0.56 | $0.97 | $2.88 | $4.77 | $149.08 | $0.25 | · | · | $0.58 | $2.11 | |
| EPS (TTM) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | · | 36,383,277 | 35,786,813 | 34,642,641 | · | 28,738,307 | 28,364,731 | 24,887,180 | · | 17,863,078 | 12,463,665 | 11,622,384 | · | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | · | 40,056,814 | 40,262,764 | 39,511,120 | · | 32,345,672 | 28,364,731 | 24,887,180 | · | 17,863,078 | 12,463,665 | 11,622,384 | · | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.50 | $3.27 | · | $3.25 | $3.00 | $2.40 | · | $0.31 | $0.15 | $0.57 | · | $1.26 | $-0.02 | $-1.30 | · | $-0.61 | |
| Revenue / Share | $0.73 | $0.69 | · | $0.51 | $0.60 | $0.50 | · | $0.35 | $0.27 | $0.13 | · | $0.02 | $0.04 | $0.05 | · | · | |
| Cash Flow / Share | · | $0.02 | · | · | · | $0.06 | · | · | · | $-0.39 | · | · | · | $-0.37 | · | · | |
| Cash / Share | $1.37 | $1.20 | · | $1.18 | $0.98 | $0.38 | · | $0.30 | $0.53 | $0.46 | · | $2.06 | $0.95 | $2.41 | · | $1.14 | |
| EPS (TTM) | $0.01 | $0.01 | · | $0.06 | $0.10 | $-0.45 | · | $-1.32 | $-2.52 | $-2.62 | · | $-3.31 | $-3.13 | $-3.79 | · | $-3.95 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $95M | $90M | · | $80M | $70M | $54M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $532.0K | $561.0K | · | $1M | $2M | $-14M | · | $-34M | $-56M | $-50M | · | $-45M | $-34M | $-37M | · | $-33M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 1259.0 | 928.0 | · | 179.2 | 136.0 | -28.3 | · | -6.8 | -3.3 | -1.8 | · | -1.2 | -1.9 | -1.5 | · | -0.8 | |
| P/S | 4.6 | 3.5 | · | 4.8 | 6.8 | 7.9 | · | 11.2 | 19.7 | 26.3 | · | 36.8 | 33.7 | 19.7 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 0.08% | 0.11% | · | 0.56% | 0.74% | -3.5% | · | -14.6% | -30.1% | -54.9% | · | -81.7% | -53.7% | -65.9% | · | -123.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $85M | $37M | $2M | $3M | $4M |
| Margin Kotor % | 86.2% | 83.4% | 69.2% | 74.8% | · |
| Margin Operasi % | 0.77% | -33.4% | -1849.0% | -1245.0% | · |
| Laba Bersih | $3M | $-26M | $-48M | $-37M | $-26M |
| EPS Dilusian | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Rasio Cepat | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $21M | $-19M | $-31M | $-25M | $-23M |
Pemilik institusional (13F) 139 pengaju · $243.2M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
139
Nilai yang dipegang
$243.2M
Posisi baru
21
Posisi yang keluar
17
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 21 (-10 vs Kuartal sebelumnya) | 17 (-3 vs Kuartal sebelumnya) | 48 (+10 vs Kuartal sebelumnya) | 29 (-8 vs Kuartal sebelumnya) | +1.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41.551.898 | 3.300.389 | 17,08% | Saham |
| BlackRock, Inc. | $34.078.638 | 2.706.802 | 14,01% | Saham |
| VANGUARD GROUP INC | $16.890.806 | 1.672.357 | 6,94% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.375.500 | 1.221.247 | 6,32% | Saham |
| Propel Bio Management, LLC | $10.971.681 | 871.460 | 4,51% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $9.232.592 | 733.115 | 3,80% | Saham |
| STATE STREET CORP | $8.552.135 | 679.280 | 3,52% | Saham |
| ALGERT GLOBAL LLC | $7.311.114 | 580.708 | 3,01% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.130.611 | 566.371 | 2,93% | Saham |
| Divisadero Street Capital Management, LP | $6.292.432 | 499.796 | 2,59% | Saham |
| MORGAN STANLEY | $5.136.506 | 407.983 | 2,11% | Saham |
| ExodusPoint Capital Management, LP | $4.530.940 | 359.884 | 1,86% | Saham |
| Private Wealth Advisors, LLC | $3.913.765 | 310.863 | 1,61% | Saham |
| Simplify Asset Management Inc. | $3.333.454 | 264.770 | 1,37% | Saham |
| NORTHERN TRUST CORP | $3.174.040 | 252.108 | 1,30% | Saham |
| GOLDMAN SACHS GROUP INC | $3.151.429 | 250.312 | 1,30% | Saham |
| ADAR1 Capital Management, LLC | $2.825.007 | 224.385 | 1,16% | Saham |
| MARSHALL WACE, LLP | $2.756.745 | 218.963 | 1,13% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $2.647.652 | 210.298 | 1,09% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.570.160 | 204.143 | 1,06% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.435.510 | 193.448 | 1,00% | Saham |
| Ikarian Capital, LLC | $2.337.548 | 185.667 | 0,96% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.290.159 | 181.903 | 0,94% | Saham |
| Nuveen, LLC | $2.286.281 | 181.595 | 0,94% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $2.177.981 | 172.993 | 0,90% | Saham |
| CIBC WORLD MARKET INC. | $2.054.789 | 163.208 | 0,84% | Saham |
| Caption Management, LLC | $1.894.795 | 150.500 | 0,78% | Opsi jual |
| Lane Generational LLC | $1.884.257 | 149.663 | 0,77% | Saham |
| HSBC HOLDINGS PLC | $1.705.848 | 135.600 | 0,70% | Saham |
| Man Group plc | $1.617.752 | 128.495 | 0,67% | Saham |
| Cubist Systematic Strategies, LLC | $1.562.514 | 145.350 | 0,64% | Saham |
| Diametric Capital, LP | $1.546.568 | 122.841 | 0,64% | Saham |
| Bank of New York Mellon Corp | $1.361.725 | 108.159 | 0,56% | Saham |
| BARCLAYS PLC | $1.359.090 | 107.950 | 0,56% | Saham |
| Caption Management, LLC | $1.259.000 | 100.000 | 0,52% | Opsi beli |
| Capital Advisors Wealth Management, LLC | $1.170.870 | 93.000 | 0,48% | Saham |
| Jump Financial, LLC | $1.108.360 | 88.035 | 0,46% | Saham |
| Jefferies Financial Group Inc. | $1.057.308 | 83.980 | 0,43% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.050.824 | 83.465 | 0,43% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.022.308 | 81.200 | 0,42% | Opsi beli |
| Stonepine Capital Management, LLC | $1.000.000 | 100.000 | 0,41% | Opsi beli |
| Caption Management, LLC | $978.243 | 77.700 | 0,40% | Saham |
| Russell Investments Group, Ltd. | $851.813 | 67.658 | 0,35% | Saham |
| FOX RUN MANAGEMENT, L.L.C. | $776.526 | 61.678 | 0,32% | Saham |
| BANK OF AMERICA CORP /DE/ | $774.587 | 61.524 | 0,32% | Saham |
| Quantbot Technologies LP | $749.860 | 59.560 | 0,31% | Saham |
| D. E. Shaw & Co., Inc. | $728.885 | 57.894 | 0,30% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $725.864 | 57.654 | 0,30% | Saham |
| Creative Planning | $609.784 | 48.434 | 0,25% | Saham |
| UBS Group AG | $525.179 | 41.714 | 0,22% | Saham |
Aktivis & pemilik 5%+ 17 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 pengajuan | 10 Feb. 2026 | 9,90% | Amandemen | · | SEC |
| Orang pelapor yang tidak diungkapkan | 16 Des. 2022 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 27 Juli 2022 | · | Pengajuan awal | Investasi pasif | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 pengajuan | 2 Agu 2010 | · | Pengajuan awal | · | SEC |
| Robert Ladd | 18 Okt. 2006 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 28 Juli 2006 | · | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan | 11 Juli 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Juni 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 8 Juni 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 24 Mei 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 28 April 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Jan. 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 6 Jan. 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Des. 2005 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Nov. 2005 | · | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan | 24 Okt. 2005 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 17 Okt. 2005 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 49 orang dalam · 13 pejabat · 17 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 8 Mei 2020 C | 25.021 | 0 | 0 | $0 |
| Sandra Pennell | Chief Financial Officer | 6 Maret 2026 P | 77.018 | 1 | 0 | $50.018 |
| Barbra Keck | Chief Financial Officer, Secretary | 8 Mei 2020 C | 12.851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 Nov. 2007 A | 3.375 | 0 | 0 | $0 |
| Martha S. Rook | CHIEF OPERATING OFFICER | 17 Feb. 2026 A | · | 0 | 0 | $0 |
| John Purpura | CHIEF OPERATING OFFICER | 8 Feb. 2023 A | 41.526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 Mei 2007 P | 160.375 | 0 | 0 | $0 |
| David L. Hoffman | GEN'L COUNSEL, CCO & SECY | 17 Feb. 2026 A | 74.330 | 0 | 0 | $0 |
| Kevin Muir | GM INTERVENTIONAL ONCOLOGY | 17 Feb. 2026 A | 18.582 | 0 | 0 | $0 |
| Vojo Vukovic | CHIEF MEDICAL OFFICER | 17 Feb. 2026 A | 168.882 | 0 | 0 | $0 |
| Johnny John | SVP CLINICAL DEV & MED AFFAIRS | 8 Feb. 2023 A | · | 0 | 0 | $0 |
| Anthony Dias | VP FINANCE | 8 Feb. 2023 A | · | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 1 Sep. 2021 A | · | 0 | 0 | $0 |
| Aharon Gil | Direktur | 13 Mei 2026 A | 3.413.468 | 0 | 0 | $0 |
| John Richard Sylvester | Direktur | 13 Mei 2026 A | 14.936 | 1 | 0 | $38.992 |
| Bridget A Martell | Direktur | 13 Mei 2026 A | · | 0 | 0 | $0 |
| Steven A J Salamon | Direktur | 13 Mei 2026 A | 3.413.468 | 0 | 0 | $0 |
| Roger G Stoll PHD | Direktur | 23 Mei 2024 A | 9.309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Direktur | 14 Des. 2022 P | 459.315 | 0 | 0 | $0 |
| Marco Taglietti | Direktur | 8 Mei 2020 C | 6.000 | 0 | 0 | $0 |
| William Dodge Rueckert | Direktur | 8 Mei 2020 C | 6.014 | 0 | 0 | $0 |
| Simon Pedder | Direktur | 1 Feb. 2019 A | · | 0 | 0 | $0 |
| Laura A Philips | Direktur | 23 Juli 2015 P | 205.299 | 0 | 0 | $0 |
| Harold S Koplewicz | Direktur | 10 Juni 2015 A | 45.052 | 0 | 0 | $0 |
| Dennis Langer | Direktur | 10 Juni 2015 A | 20.000 | 0 | 0 | $0 |
| Jonathan Lewis | Direktur | 30 Juni 2008 A | 10.000 | 0 | 0 | $0 |
| Mark Corigliano | Direktur | 16 April 2007 M | 198.176 | 0 | 0 | $0 |
| Daniel Isdaner | Direktur | 16 April 2007 M | 253.668 | 0 | 0 | $0 |
| Elizabeth Czerepak | · | 13 Mei 2026 A | · | 0 | 0 | $0 |
| Gerard J Michel | · | 2 Maret 2026 P | 342.034 | 2 | 0 | $198.447 |
| Laura Brege | · | 7 Juli 2014 A | 11.678 | 0 | 0 | $0 |
| Tasos Konidaris | · | 7 Juli 2014 A | 11.678 | 0 | 0 | $0 |
| Gabriel Leung | · | 7 Juli 2014 A | 21.485 | 0 | 0 | $0 |
| Douglas G Watson | · | 7 Juli 2014 A | 136.664 | 0 | 0 | $0 |
| Graham G Miao | · | 14 Nov. 2013 A | 54.000 | 0 | 0 | $0 |
| Peter J Graham | · | 14 Nov. 2013 A | 15.000 | 0 | 0 | $0 |
| William M Appling | · | 15 Juli 2013 A | · | 0 | 0 | $0 |
| Krishna Kandarpa | · | 11 Maret 2013 A | 159.000 | 0 | 0 | $0 |
| Harold Mapes | · | 11 Maret 2013 A | 17.000 | 0 | 0 | $0 |
| Eamonn P Hobbs | · | 11 Maret 2013 A | 162.000 | 0 | 0 | $0 |
| Agustin V Gago | · | 11 Maret 2013 A | 80.944 | 0 | 0 | $0 |
| Robert Ladd | · | 15 Juni 2012 A | 69.534 | 0 | 0 | $0 |
| David Mcdonald | · | 10 Maret 2011 A | 47.706 | 0 | 0 | $0 |
| Pamela Reilly Contag | · | 1 Des. 2010 A | 8.507 | 0 | 0 | $0 |
| Richard Taney | · | 10 Des. 2009 A | 211.485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | · | 12 Okt. 2009 A | · | 0 | 0 | $0 |
| KOLY M S /FA/ | · | 26 Jan. 2007 X | 775.360 | 0 | 0 | $0 |
| Victor Nevins | · | 12 Okt. 2006 M | 180.007 | 0 | 0 | $0 |
| VENKOL TRUST | · | 10 Nov. 2004 J | 892.649 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 16 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,11% | 97.206 SH | 11 Sep. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21.358 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 743.359 SH | 11 Sep. 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.376 SH | 2 Okt. 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 13.736 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165.177 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 70.373 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 39.522 SH | 11 Sep. 2026 | Harian |
| DFSU · Dimensional ETF Trust | 0,00% | 3.297 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43.746 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 12.489 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304.809 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889.410 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.438 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.475 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 228.409 SH | 11 Sep. 2026 | Harian |
DCTH Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 12 analis
BELI
Target median
$22.00
+42,0%
3 25,0%
Beli Kuat
8 66,7%
Beli
1 8,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-09-29Target rata-rata $24.00 +54,9%
← Di bawah semua target
Harga saat ini $15.49
Rendah$21.00
Rata-rata$24.00
Tinggi$32.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | · |
| ANGO | · | -13.0 | 9.5% | · | · | · |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| SSII | · | -94.7 | 105.7% | · | · | · |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026